Description
Dufalak Frut (Lactulose) Oral Solution 667 mg/ml. – 200 ml. Vial
Dufalak Frut is an oral solution containing lactulose, with a concentration of 667 mg/ml. This medication comes in a 200 ml. vial and is commonly used for the treatment of various gastrointestinal conditions. Below is a comprehensive overview of Dufalak Frut, including its uses, dosage, side effects, and precautions.
Uses of Dufalak Frut:
Dufalak Frut is primarily prescribed for the treatment of constipation. Lactulose, the active ingredient in this medication, works by drawing water into the colon, softening the stool and promoting bowel movements. It is also sometimes used to treat hepatic encephalopathy, a condition that occurs when the liver is unable to remove toxins from the blood.
Dosage and Administration:
The dosage of Dufalak Frut may vary depending on the individual’s condition and response to treatment. It is important to follow the dosage instructions provided by your healthcare provider or as indicated on the prescription label. Generally, the usual starting dose for constipation in adults is 15-30 ml. (10-20 g) per day, which can be adjusted based on the response.
For hepatic encephalopathy, the dosage may be higher and is typically determined by the healthcare provider based on the severity of the condition. It is important to take Dufalak Frut as directed and to drink plenty of water while using this medication to prevent dehydration.
Side Effects of Dufalak Frut:
Like all medications, Dufalak Frut may cause side effects in some individuals. Common side effects of lactulose may include bloating, gas, cramps, and diarrhea. These side effects are usually mild and temporary. However, if you experience severe or persistent side effects while taking Dufalak Frut, it is important to contact your healthcare provider.
Precautions and Considerations:
Before taking Dufalak Frut, it is important to inform your healthcare provider about any pre-existing medical conditions, allergies, or medications you are currently taking. This medication may not be suitable for individuals with certain conditions such as galactose intolerance, diabetes, or electrolyte imbalances.
It is also important to note that Dufalak Frut should not be used as a long-term solution for chronic constipation without consulting a healthcare provider. Prolonged use of laxatives like lactulose may lead to dependence and disrupt normal bowel function.
Conclusion:
Dufalak Frut is a widely used medication for the treatment of constipation and hepatic encephalopathy. With its active ingredient lactulose, it helps to soften stool and promote bowel movements. By following the prescribed dosage and guidelines, individuals can effectively manage their gastrointestinal conditions with the help of Dufalak Frut.